arrow
C

Claire Flaujac

chu-rennes
H指数:15
被引数:894

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Laboratory Monitoring of UFH in Different Settings (DEXHEP Study): Association between Anti-Xa Levels, Platelet Factor 4 (PF4) Plasma Levels and Dextran Sulfate

不同临床环境下UFH的实验室监测(DEXHEP研究):抗Xa水平、血小板因子4(PF4)血浆水平与右旋糖酐硫酸盐之间的关系

2025-12-010
OA
Drug-Specific Calibration: A Solution to Reagent Variability in Extended Half-Life Factor IX Activity Measurements

药物特异性校准:解决延长半衰期因子IX活性测定中试剂变异性的方案

2025-09-010
PRE
Sensitivity and specificity of strategies to identify patients with hemostasis abnormalities leading to an increased risk of bleeding before scheduled intervention: the Hemorisk study
2024-11-012
PRE
Obstetrical complications in hereditary fibrinogen disorders: the Fibrinogest study
2023-08-0110
PRE
Factors Influencing anti-Xa assays: A Multicenter Prospective Study in Critically Ill and Noncritically Ill Patients Receiving Unfractionated Heparin
2023-06-159
PRE
GFHT proposals on the practical use of argatroban - With specifics regarding vaccine-induced immune thrombotic thrombocytopaenia (VITT)
2021-12-018
PREAI
Real Life Population Pharmacokinetics Modelling of Eight Factors VIII in Patients with Severe Haemophilia A: Is It Always Relevant to Switch to an Extended Half-Life?
2020-04-2112
OAAI
Multicentre evaluation of CK Prest for assaying plasma levels of factor IX fused with albumin (Idelvion)
2019-07-115
PREAI
Evaluation of dabigatran, rivaroxaban and apixaban target-specific assays in a multicenter French study
2017-10-0121
PREAI